pseudobulbar affect

The experimental drug Zenvia continued to show benefit in a 12-week extension study in people with "pseudobulbar affect" (uncontrolled emotional expression)

posted on April 12, 2010 - 8:22pm
The experimental drug Zenvia, developed by Avanir Pharmaceuticals as a treatment for unwanted laughing/crying spells in ALS, has shown continued promise in lessening the frequency of such episodes in people with amyotrophic lateral sclerosis (ALS).

New content is being added every day. Please check back again.